Clinical trial
Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients
NCT00962676 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients
- Lead sponsor
- Yonsei University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- December 31, 2010
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.